Dalteparin v placebo for chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease at 6 months*

OutcomeDalteparinPlaceboRRR (95% CI)NNT (CI)
*Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.
Amputation5%19%76% (6 to 94)7 (4 to 142)